23
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Prediction of Prognosis Following Fludarabine Used as Secondary Therapy for Chronic Lymphocytic Leukemia

, , , , , & show all
Pages 71-85 | Received 15 Sep 1999, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Marco Montillo, Francesca Ricci & Alessandra Tedeschi. (2006) Role of fludarabine in hematological malignancies. Expert Review of Anticancer Therapy 6:9, pages 1141-1161.
Read now
Thomas Elter, Michael Hallek & Andreas Engert. (2006) Fludarabine in chronic lymphocytic leukaemia. Expert Opinion on Pharmacotherapy 7:12, pages 1641-1651.
Read now
Lev Shvidel, Mordechai Shtalrid, Osnat Bairey, Naomi Rahimi-Levene, Gilles Lugassy, Ofer Shpilberg, Aaron Polliack & Alain Berrebi. (2003) Conventional Dose Fludarabine-based Regimens are Effective but have Excessive Toxicity in Elderly Patients with Refractory Chronic Lymphocytic Leukemia. Leukemia & Lymphoma 44:11, pages 1947-1950.
Read now

Articles from other publishers (24)

Nina Kreuzberger, Johanna AAG Damen, Marialena Trivella, Lise J Estcourt, Angela Aldin, Lisa Umlauff, Maria DLA Vazquez-Montes, Robert Wolff, Karel GM Moons, Ina Monsef, Farid Foroutan, Karl-Anton Kreuzer & Nicole Skoetz. (2020) Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews 2020:7.
Crossref
Arnon P. Kater & Sanne H. Tonino. (2010) Standards for the Treatment of Relapsed Chronic Lymphocytic Leukemia: A Case-Based Study. Clinical Lymphoma Myeloma and Leukemia 10, pages S34-S41.
Crossref
Abeer N. AbouYabis & Christopher R. Flowers. (2006) Treatment Options for Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia. Clinical Leukemia 1:1, pages 46-56.
Crossref
Angiolo Gadducci, Enrico Sartori, Fabio Landoni, Paolo Zola, Tiziano Maggino, Nicoletta Colombo, Antonio Fanucchi, Francesca Chiudinelli, Mariateresa LaPresa & Anna Maria Ferrero. (2005) Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: Results of a multicenter retrospective Italian study. Gynecologic Oncology 98:1, pages 118-123.
Crossref
P. Kokhaei, M. Palma, H. Mellstedt & A. Choudhury. (2005) Biology and treatment of chronic lymphocytic leukemia. Annals of Oncology 16, pages ii113-ii123.
Crossref
John G. Gribben. (2005) Salvage Therapy for CLL and the Role of Stem Cell Transplantation. Hematology 2005:1, pages 292-298.
Crossref
Clifford A. Hudis, Simon Van Belle, Jose Chang & Karsten Muenstedt. (2004) rHuEPO and Treatment Outcomes: the Clinical Experience. The Oncologist 9:S5, pages 55-69.
Crossref
V Rizouli & J.G Gribben. (2004) The role of stem cell transplantation in chronic lymphocytic leukemia. Seminars in Hematology 41:3, pages 246-253.
Crossref
D. Oscier, C. Fegan, P. Hillmen, T. Illidge, S. Johnson, P. Maguire, E. Matutes & D. Milligan. (2004) Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. British Journal of Haematology 125:3, pages 294-317.
Crossref
Chadi Nabhan, Ronald B Gartenhaus & Martin S Tallman. (2004) Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era. Leukemia Research 28:5, pages 429-442.
Crossref
William G Wierda, Michael J Keating & Susan O??Brien. (2004) Refractory Chronic Lymphocytic Leukemia. American Journal of Cancer 3:3, pages 163-178.
Crossref
Alessandra Ferrajoli, Michael J. Keating & Susan M. O’Brien. 2004. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 241 254 .
Gary Van Zant & Ying Liang. (2003) The role of stem cells in aging. Experimental Hematology 31:8, pages 659-672.
Crossref
Simon Jean-Pierre Van Belle & Véronique Cocquyt. (2003) Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Critical Reviews in Oncology/Hematology 47:1, pages 1-11.
Crossref
William S. VelasquezDanika LewThomas M. GroganC. Harris SpiridonidisStanley P. BalcerzakShaker R. DakhilThomas P. MillerKeith S. LanierRobert A. ChapmanRichard I. Fisher. (2003) Combination of Fludarabine and Mitoxantrone in Untreated Stages III and IV Low-Grade Lymphoma: S9501. Journal of Clinical Oncology 21:10, pages 1996-2003.
Crossref
Kashif Hussain, Joseph J. Mazza & Lawrence H. Clouse. (2003) Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): Case report and review of the literature. American Journal of Hematology 72:3, pages 212-215.
Crossref
Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, Maria N. Dimopoulou, Marina P. Siakantaris, Flora N. Kontopidou & Maria K. Angelopoulou. (2002) B‐chronic lymphocytic leukemia: practical aspects. Hematological Oncology 20:3, pages 103-146.
Crossref
AG Bosanquet, I Sturm, T Wieder, F Essmann, MI Bosanquet, DJ Head, B Dörken & PT Daniel. (2002) Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Leukemia 16:6, pages 1035-1044.
Crossref
T Robak & M Kasznicki. (2002) Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Leukemia 16:6, pages 1015-1027.
Crossref
R Oudat, MJ Keating, S Lerner, S O'Brien & M Albitar. (2002) Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission. Leukemia 16:4, pages 632-635.
Crossref
David I. Marks. (2001) Allogeneic transplantation for leukaemia using unrelated donors. Best Practice & Research Clinical Haematology 14:4, pages 793-805.
Crossref
. (2000) Current Awareness. Hematological Oncology 18:3, pages 121-128.
Crossref
Kathleen Kaysinger. (2000) The 41st Annual Meeting of the American Society of Hematology, New Orleans, LA December 3–7, 1999. Clinical Lymphoma 1:1, pages 17-26.
Crossref
M. J. Keating. 1997. Acute Leukemias VI. Acute Leukemias VI 380 387 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.